Clinical trial
A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients…
NCT00272207 · Winnipeg Regional Health Authority, Other · Completed
Key facts
| NCT number | NCT00272207 |
|---|---|
| Title | A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia |
| Official title | A Randomized Double-blinded Placebo Controlled Trial Assessing the Effect of the Oral Cannabinoid Nabilone on Pain and Quality of Life in Patients With Fibromyalgia |
| Lead sponsor | Winnipeg Regional Health Authority, Other |
| Collaborators | Valeant Canada Limited Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | Nabilone |
| Enrollment | 40 |
| Start date | Apr 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jan 4, 2006 |
| Last update posted | Aug 25, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: